Importantly, Y-box binding protein-1 (YB-1) is another transcription factor that regulates clusterin expression and is strongly involved in therapeutic resistance of PCa to paclitaxel and enzalutamide treatments [97,257]. Here, CLU is linked to posterior cortical atrophy.